Clinical trial
The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using…
NCT00216866 · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other · Completed
Key facts
| NCT number | NCT00216866 |
|---|---|
| Title | The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis |
| Official title | A Pilot Study of Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis of the Upper Extremity |
| Lead sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Embolism and Thrombosis |
| Intervention type | Drug |
| Interventions | Dalteparin, Warfarin |
| Enrollment | 70 |
| Start date | Sep 1, 2002 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 28, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: